Anti-Amyloid-Β Monoclonal Antibodies as Promising Disease-Modifying Therapies in Alzheimer's Disease: A Focus on Aducanumab, Lecanemab, Crenezumab, Gantenerumab and Solanezumab

AuthID
 P-00Z-7NS
3
Author(s)
Melo, VSD
·
Rodrigues, CA
·
Document Type
Abstract
Year published
2023
Published
in EUROPEAN PSYCHIATRY, ISSN: 0924-9338
Volume: 66, Pages: S297-S297 (1)
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:001060676600639
Source Identifiers
ISSN: 0924-9338
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service